Bioaccess Ivs
CVE-2023-38954
CRITICAL
Vulnerability Assessment
| Weakness |
CWE
OWASP Top 10:2025
A05:2025 - Injection
ASVS 5.0
V1 - Encoding and Sanitization Parameterized queries, prepared statements
MITRE ATT&CK
2 techniques across 2 tactics: Initial Access, Persistence The technique list with ATT&CK links and the kill-chain view is part of the Basic plan and up. |
| Impact | CVSS score of 9.8 (CRITICAL). Attack characteristics: network attack vector, low complexity, no privileges required, no user interaction not required. EPSS exploitation probability: 0.52%. |
| Exploit ScenarioDerived | A remote attacker could execute arbitrary SQL commands against the database by sending crafted requests to the affected application. No authentication is required to exploit this vulnerability. |
Get an e-mail when this CVE is exploited, patched or re-scored. Free account.
Alert meAnalysisAI
ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability. Rated critical severity (CVSS 9.8), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.
RemediationAI
No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Use parameterized queries/prepared statements. Never concatenate user input into SQL. Apply least-privilege database permissions.
Affects your stack
Find out whether the stacks and servers you run are on an affected version.
Checking this CVE against your own stacks and servers is part of the Basic plan and up.
Technical ContextAI · show details
This vulnerability is classified as SQL Injection (CWE-89), which allows attackers to execute arbitrary SQL commands against the database. ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability. Affected products include: Zkteco Bioaccess Ivs.
Know when Bioaccess Ivs gets its next vulnerability
- Watch products and get an email when something new is published
- Check this CVE against your own stack and servers
- Exploit and PoC references, threat intelligence from 22 sources
No credit card · 7-day full trial
Severity by source
AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
Primary rating from NVD · only source for this CVE.
CVSS VectorNVD
DescriptionNVD
ZKTeco BioAccess IVS v3.3.1 was discovered to contain a SQL injection vulnerability.
Threat Intelligence Overview
NVD
CVE.org
EPSS
VulDB
How this decision was reached
The engine reads each signal below and applies a fixed list of rules from top to bottom. The first rule that matches sets the recommended action – like a statement, every line is shown.
What every action level means
SSVC AssessmentENISA
Priority Score
Attack Technique
SQL injection exploits the way applications construct database queries by mixing user input directly into SQL statements.
Affected Products (CPE)NVD
More in Bioaccess Ivs
View allA path traversal vulnerability in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to read arbitrary files v
ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to obtain sensitive information about all managed devices,
An access control issue in ZKTeco BioAccess IVS v3.3.1 allows unauthenticated attackers to arbitrarily close and open th
GitHub PoC
Exploit-DB